Clinical Trial

Identification of Biomarkers in Spinocerebellar Ataxia 3

Study Description

Identification of Biomarkers in Spinocerebellar Ataxia 3

The purpose of this study is to examine the differences in cerebral spinal fluid (CSF) and blood of patients with spinocerebellar ataxias and healthy volunteers. The goal of this project is to identify new biomarkers that are useful for characterizing spinocerebellar ataxias and identify targets for treatment or prevention of this condition.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Specimen Collection

No interventions take place as part of study participation- only specimen collection occurs for both cohorts.

Additional Information

Official Study Title

Identification of Biomarkers in Spinocerebellar Ataxia 3

Clinical Trial ID

NCT03885167

ParticipAid ID

en5XPd